BioCorRx (BICX) Change in Account Payables (2016)
BioCorRx (BICX) has disclosed Change in Account Payables for 7 consecutive years, with $328890.0 as the latest value for Q4 2016.
- Quarterly Change in Account Payables rose 261.08% to $328890.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was -$42740.0 through Dec 2016, down 108.89% year-over-year, with the annual reading at -$42740.0 for FY2016, 108.89% down from the prior year.
- Change in Account Payables hit $328890.0 in Q4 2016 for BioCorRx, up from -$126365.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $328890.0 in Q4 2016 to a low of -$250738.0 in Q2 2016.
- Historically, Change in Account Payables has averaged $47209.6 across 5 years, with a median of $65519.0 in 2012.
- Biggest YoY gain for Change in Account Payables was 442.8% in 2012; the steepest drop was 989.2% in 2012.
- Year by year, Change in Account Payables stood at $44323.0 in 2012, then surged by 191.1% to $129026.0 in 2013, then increased by 15.44% to $148942.0 in 2014, then plummeted by 38.85% to $91085.0 in 2015, then surged by 261.08% to $328890.0 in 2016.
- Business Quant data shows Change in Account Payables for BICX at $328890.0 in Q4 2016, -$126365.0 in Q3 2016, and -$250738.0 in Q2 2016.